John D. Chetwood

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Outcomes of first and further decompensation events in advanced chronic liver disease: a multi-centre competing risks analysis.

Outcomes of first and further decompensation events in advanced chronic liver disease: a multi-centre competing risks analysis.

Journal: Hepatology international

Published: February 10, 2026

Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter?

Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter?

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 08, 2026

IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia.

IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia.

Journal: Journal of gastroenterology and hepatology

Published: May 29, 2025

Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease.

Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics

Published: April 25, 2025

Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases.

Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases.

Journal: Therapeutic advances in gastroenterology

Published: March 12, 2025

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Journal: The American journal of gastroenterology

Published: January 14, 2025

Editorial: Where to Start in Ulcerative Colitis?

Editorial: Where to Start in Ulcerative Colitis?

Journal: Alimentary pharmacology & therapeutics

Published: December 19, 2024

Letter: Bowel Preparation Quality in Patients With Crohn's Disease.

Letter: Bowel Preparation Quality in Patients With Crohn's Disease.

Journal: Alimentary pharmacology & therapeutics

Published: October 07, 2024

Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial data.

Letter: Ulcerative proctitis-A step towards addressing the knowledge gap, and a call for greater detail, in trial data.

Journal: Alimentary pharmacology & therapeutics

Published: September 19, 2024

Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.

Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.

Journal: Alimentary pharmacology & therapeutics

Published: July 29, 2024

Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) Study.

Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) Study.

Journal: The American journal of gastroenterology

Published: July 06, 2024

Genital rash: A manifestation of metastatic Crohn's disease.

Genital rash: A manifestation of metastatic Crohn's disease.

Journal: Clinical case reports

Published: June 20, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026